RYTM · Rhythm Pharmaceuticals, Inc. · Debt
$115.02
+5.16 (+4.70%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$7.97B
Shares
69.33M
Volume · Nov 13
1.16M
Avg daily vol (3M)
997.95K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Read debt and covenant terms in your AI or your code through MCP and the API →Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-09-30 | USD 731,000 | 10-Q filed 2026-11-03 |
| Current portion of long-term debt | 2026-09-30 | USD 14,751,000 | 10-Q filed 2026-11-03 |
| Noncurrent debt carrying amount | 2026-09-30 | USD 87,915,000 | 10-Q filed 2026-11-03 |
| Noncurrent operating lease liabilities | 2026-09-30 | USD 2,784,000 | 10-Q filed 2026-11-03 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1649904
CUSIP
76243J105
13F (30d)
263 filings
226 filers
Visit website
Investor relations